Thrive Capital Management (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,307
| Closed | -$202K | – | 172 |
|
|
2025
Q1 | $202K | Buy |
+3,307
| New | +$202K | 0.12% | 111 |
|
|
2024
Q4 | – | Sell |
-4,313
| Closed | -$223K | – | 105 |
|
|
2024
Q3 | $223K | Buy |
+4,313
| New | +$223K | 0.11% | 171 |
|
|
2024
Q2 | – | Sell |
-3,888
| Closed | -$211K | – | 184 |
|
|
2024
Q1 | $211K | Buy |
+3,888
| New | +$211K | 0.11% | 115 |
|
|
2022
Q4 | – | Sell |
-3,510
| Closed | -$250K | – | 116 |
|
|
2022
Q3 | $250K | Sell |
3,510
-569
| -14% | -$40.5K | 0.17% | 94 |
|
|
2022
Q2 | $314K | Buy |
4,079
+1,069
| +36% | +$82.3K | 0.22% | 75 |
|
|
2022
Q1 | $220K | Buy |
+3,010
| New | +$220K | 0.13% | 89 |
|